Figure S1 from A Phase I Study of Pelabresib (CPI-0610), a Small-Molecule Inhibitor of BET Proteins, in Patients with Relapsed or Refractory Lymphoma

Authors:

Abstract
CONSORT diagram of patient disposition throughout study